<p>For infections, all patients were followed until drop out, death or the end of the study.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Survivors (65) included participants who completed the study (32), participants who died before c...
<p>Final follow-up status by demographic and baseline characteristics of study patients on anti-retr...
<p>Out of 162 patients who were eligible to the study, 73 patients were enrolled in the study, and 6...
<p>Follow-up of patients (died, lost to contact) in the community-based and hospital-based cohorts o...
*<p>Restricted to patients who had virologic suppression at study entry, n = 2517.</p>**<p>Patients ...
<p>The majority of patients not meeting inclusion criteria had passed away, were free of pain or wer...
Demographic and clinical characteristics at BL and organizational characteristics at the last FU car...
1<p>Includes cases lost to follow-up within five years of diagnosis.</p>2<p>Excludes cases lost to f...
Study flow chart, showing how the COVID-19 survivors were selected to participate in this follow-up ...
<p>Includes subjects interviewed as well as those who are known to have died;</p
<p>At each follow-up time point, the number of patients attending is given. Patient groups reaching ...
<p>Characteristics of patients followed from 10 years after start of ART who died, were lost to foll...
<p>Patient enrolment in the antiretroviral treatment service and outcomes during follow-up.</p
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Survivors (65) included participants who completed the study (32), participants who died before c...
<p>Final follow-up status by demographic and baseline characteristics of study patients on anti-retr...
<p>Out of 162 patients who were eligible to the study, 73 patients were enrolled in the study, and 6...
<p>Follow-up of patients (died, lost to contact) in the community-based and hospital-based cohorts o...
*<p>Restricted to patients who had virologic suppression at study entry, n = 2517.</p>**<p>Patients ...
<p>The majority of patients not meeting inclusion criteria had passed away, were free of pain or wer...
Demographic and clinical characteristics at BL and organizational characteristics at the last FU car...
1<p>Includes cases lost to follow-up within five years of diagnosis.</p>2<p>Excludes cases lost to f...
Study flow chart, showing how the COVID-19 survivors were selected to participate in this follow-up ...
<p>Includes subjects interviewed as well as those who are known to have died;</p
<p>At each follow-up time point, the number of patients attending is given. Patient groups reaching ...
<p>Characteristics of patients followed from 10 years after start of ART who died, were lost to foll...
<p>Patient enrolment in the antiretroviral treatment service and outcomes during follow-up.</p
<p>*Participants who had withdrawn, were lost to follow-up or had died were not invited.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
<p>Survivors (65) included participants who completed the study (32), participants who died before c...
<p>Final follow-up status by demographic and baseline characteristics of study patients on anti-retr...